Products - Diabetes | Topic | NICE

Showing 7 products

Date | Sort by Title

Product type: GuidanceRemove ‘Product type: Guidance’ filter
New and updated: New in the last 6 monthsRemove ‘New and updated: New in the last 6 months’ filter

Sotagliflozin with insulin for treating type 1 diabetes (TA622)
Product type:
Guidance
Programme:
Technology appraisal guidance
Published date:
12 February 2020
Empagliflozin for type 1 Diabetes Mellitus, adjunct to insulin ID1275
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Dulaglutide for treating type 2 diabetes [ID1451]
Status:
Proposed
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Ranibizumab for treating diabetic retinopathy [ID1592]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Diabetes in pregnancy: management from preconception to the postnatal period
Status:
In development
Programme:
NICE guideline
Expected publication date:
TBC
Canagliflozin for treating chronic kidney disease in people with type 2 diabetes [ID1653]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC
Sotagliflozin for treating type 2 diabetes [ID1657]
Status:
In development
Programme:
Technology appraisal guidance
Expected publication date:
TBC